Medications, such as steroids, certain NSAIDs, and biologics, may help reduce the odds of nasal polyp recurrence. Avoiding triggers, such as cigarette smoke or cold, dry air, can also help keep nasal ...

MomMed, a trusted maternal and family wellness brand, today announced a strategic partnership with nasal care innovator ...

Cystic fibrosis (CF) is a rare autosomal recessive disorder that affects numerous systems of the body. It is a complicated ...

For an estimated 30 million American adults, the simple act of breathing can be a daily struggle. That’s one in eight adults across the U.S.

The US Food and Drug Administration (FDA) has approved dupilumab (Dupixent) as the first targeted therapy for bullous ...

Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid  Approval based on pivotal results showing improvements in sustained disease remission and ...

Sanofi & Regeneron’s Dupixent receives US FDA approval to treat patients with bullous pemphigoid: Paris Saturday, June 21, 2025, 12:00 Hrs [IST] The US Food and Drug Administrat ...

Approval based on pivotal results showing improvements in sustained disease remission and reductions in itch and oral corticosteroid use co ...

Adults on dupilumab for severe chronic rhinosinusitis with nasal polyps had better outcomes than those who used omalizumab, ...

The identification of immune genes that distinguish patients with CRSwNP from healthy controls offers insight into disease ...